Latest filing published 09 Sept 2025 for EQL Pharma AB.
Filing timeline
BuySaleInsider track record
Cornelia Lindström: trading record in brief
Cornelia Lindström is a declared insider of EQL Pharma AB (chief executive), with filings sourced from Finansinspektionen. We count 7 filings; the first trade dates from 1 September 2021 and the latest from 9 September 2025.
On the market, this insider has only sold: 1 sale, €283k in total. Since January 2025: no purchases and 1 sale on the market.
Most recently, on 9 September 2025, the filings show a transaction in EQL Pharma AB. The median gap between a trade and its publication by Finansinspektionen is 1 day. For comparison, MAR article 19 gives managers three business days to notify a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Cornelia Lindström
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 38,370 shares0AktieISIN SE0005497732FI:csv-fe31b21fcd9fd952d21c
- 38,370 shares0AktieISIN SE0005497732FI:A003S141-2
- 38,370 shares0AktieISIN SE0005497732FI:csv-3355a1ebc4a985c2183b
- 46,000 shares0TeckningsoptionFI:csv-ff9177742b2c9163c8f0
- 38,370 shares@ SEK 81.0048.5% of flowAktieISIN SE0005497732FI:csv-093de56b7549d39f51ce
- 46,000 shares@ SEK 72.0551.5% of flowAktieISIN SE0005497732FI:csv-13d2aacd0f9ba56a245a
- 46,000 shares@ SEK 2.23100.0% of flowTeckningsoptionFI:csv-8ca5baf5d7d7fcc3268e
7 of 7 declarations